To uncover the full antiviral potential of ZIKV-specific CD8 T cells in controlling a potentially lethal infection in the CNS, we first chose to work with B cell deficient mice that have an almost intact CD8 T cell compartment, but are unable to produce antibodies (42). Here, CD8A is linked to infection.